Our custom in vivo glycobiology disease model service offers tailored solutions for researchers seeking to investigate diseases related to sugars or glycosylation. Leveraging cutting-edge techniques and expertise, we specialize in Developing High-quality Custom Models to meet your specific research needs, accelerating scientific discovery in glycobiology.

Multiple Technologies Based Glycobiology Disease Model Service

Advanced custom services offered by CD BioGlyco provide researchers with powerful tools to create tailored disease models that accurately recapitulate glycobiology-related disorders, including diabetes, neurodegenerative diseases, cancer, cardiovascular disorders, metabolic syndrome, and rare genetic disorders. With our expertise in molecular biology, genome editing, and transgenic technologies, we empower researchers to explore novel therapeutic strategies and accelerate the development of innovative treatments for debilitating diseases. Moreover, CD BioGlyco also provides the glycobiology disease model construction service for our clients to choose from. based on our in vivo glycobiology disease model, we offer clients the in vivo glycobiology disease model screening service.

Our skilled team uses embryonic stem cell technology to precisely modify the genomes of mice, allowing for the generation of genetically engineered mouse models (GEMMs) with targeted gene mutations or knockouts relevant to glycobiology and associated diseases. This approach enables the study of gene function, disease mechanisms, and therapeutic interventions in vivo.

Leveraging the revolutionary CRISPR-Cas technology, our experts offer CRISPR-Pro-based services for the generation of genetically modified mice with unparalleled efficiency and precision. Whether it involves gene editing, knock-in, knock-out, or point mutations, our CRISPR-based approach facilitates rapid and specific genome modifications, accelerating research in glycobiology and disease modeling.

Our transgenic services enable the generation of mice or rats expressing foreign genes of interest under the control of tissue-specific or inducible promoters relevant to glycobiology research. By introducing transgenes into the genome of rodents, researchers can investigate the functional consequences of gene overexpression or gain-of-function mutations in vivo, elucidating their roles in disease pathogenesis and therapeutic targets.

CD BioGlyco's custom in vivo glycobiology disease model service offers valuable applications across various research areas, here are some of the disease research that our models can be used in.

• Diabetes research: Custom disease models can be tailored to study the pathogenesis, progression, and potential treatments for diabetes mellitus and its complications.
• Neurodegenerative disease research: Our custom models facilitate research into neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS).
• Cancer biology investigations: Clients can use our custom disease models to explore the role of glycosylation in cancer initiation, progression, metastasis, and therapy resistance.
• Cardiovascular disease research: Custom disease models are instrumental in studying cardiovascular disorders such as atherosclerosis, myocardial infarction, heart failure, and hypertension.
• Metabolic syndrome investigations: Our custom models enable researchers to study metabolic syndrome and its associated complications, including obesity, dyslipidemia, fatty liver disease, and metabolic inflammation.
• Rare diseases research: Custom disease models can be developed to investigate rare genetic disorders characterized by abnormal glycosylation patterns, such as congenital disorders of glycosylation (CDG).

Publication Data

Applications

• Our models are adaptable to a broad spectrum of research areas, encompassing but not limited to autoimmune diseases, cancer, infectious diseases, infectious diseases, and so on.
• Researchers can gain a deeper understanding of the pathophysiology of diseases by studying glycosylation patterns in vivo. This knowledge can reveal new pathways and processes involved in disease development and progression, potentially leading to the discovery of novel therapeutic targets.
• The ability to study glycosylation in vivo enables the evaluation of potential therapeutic agents and their impact on glycosylation patterns. This crucial step in drug development helps optimize drug efficacy and minimize side effects, leading to the creation of more effective and safer treatments.

Advantages of Custom Models

• Our custom models precisely replicate the disease characteristics relevant to your research interests, providing tailored research tools to address your specific questions.
• Optimized design of custom models allows for faster acquisition of research results, expediting research progress and outcomes.
• With our experienced team and quality-assured custom models, we minimize research risks and ensure the reliability of your study outcomes.
• We offer personalized technical support and expert guidance throughout the project, ensuring the success of your research endeavors.

At CD BioGlyco, our commitment is to provide you with high-quality custom disease models that meet your needs and contribute to the advancement of glycobiology research. Please feel free to contact us to learn more and discuss your research requirements.